Voltage-sensor conformational microenvironments encode isoform-selective ion channel activation
Data files
Sep 08, 2026 version files 1.05 MB
-
Figure_1E-G_KCNQ3_Carnosic_acid_Dose_Response_-_Gmax.csv.xlsx
70.91 KB
-
Figure_2A_KCNQ3_Alanine_Mutants_-_Delta_Voltage-dependence_Shift_vs_WT.csv.xlsx
10.97 KB
-
Figure_2B_KCNQ3_Alanine_Mutants_-_10_uM_Carnosic_acid_Delta_Voltage-dependence_Shift.csv.xlsx
11.04 KB
-
Figure_2F_KCNQ3-S228A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
27.76 KB
-
Figure_2H_KCNQ3-R242A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
27.65 KB
-
Figure_2H_KCNQ3-R243A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
27.30 KB
-
Figure_2J_KCNQ3-R236A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
33.80 KB
-
Figure_2K_KCNQ3-L226A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
35.35 KB
-
Figure_2M_KCNQ3-R236A_Carnosic_acid_Dose_Response_-_Gmax.csv.xlsx
71.75 KB
-
Figure_2N_KCNQ3-L226A_Carnosic_acid_Dose_Response_-_Gmax.csv.xlsx
88.66 KB
-
Figure_3B_KCNQ3-L226F_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
33.77 KB
-
Figure_3B_KCNQ3-L226V_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
29.87 KB
-
Figure_3B_KCNQ3-L226W_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
30.26 KB
-
Figure_3C_Baseline_Voltage-dependence_Shift_vs_KCNQ3.csv.xlsx
9.56 KB
-
Figure_3D_10_uM_Carnosic_acid_-_Delta_Voltage-dependence_Shift.csv.xlsx
9.58 KB
-
Figure_3F_KCNQ3-L226Q_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
29.77 KB
-
Figure_3F_KCNQ3-L226S_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
33.19 KB
-
Figure_3H_KCNQ3-L226E_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
29.47 KB
-
Figure_3H_KCNQ3-L226R_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
26.71 KB
-
Figure_3I_Baseline_Voltage-dependence_Shift_vs_KCNQ3.csv.xlsx
9.55 KB
-
Figure_6E_KCNQ3-S225-A-L226_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
29.72 KB
-
Figure_6F_KCNQ3-L222F__S225-A-L226_100_uM_Carnosic_acid_-_EM.csv.xlsx
9.25 KB
-
Figure_6F_KCNQ3-S225-A-L226_100_uM_Carnosic_acid_-_EM.csv.xlsx
9.27 KB
-
Figure_7D_KCNQ2-Q3_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
28.68 KB
-
Figure_7F_KCNQ2-A196del_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
26.46 KB
-
Figure_7F_KCNQ2-F192L__A196del_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
26.42 KB
-
Figure_7F_KCNQ2-F192L_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
26.79 KB
-
Figure_7G_KCNQ2_Mutants_100_uM_Carnosic_acid_-_Delta_Voltage-dependence_Shift.csv.xlsx
10.20 KB
-
Figure_7H_KCNQ2_Mutants_100_uM_Carnosic_acid_-_Delta_EM_Shift.csv.xlsx
10.12 KB
-
Figure_9A_Tritiated_GABA_vs_Carnosic_acid.csv.xlsx
10.05 KB
-
Figure_9C_KCNQ3_5_uM_Carnosic_acid_-_Gmax.csv.xlsx
25.87 KB
-
Figure_9D_KCNQ3_5_uM_Carnosic_acid_-_EM.csv.xlsx
9.13 KB
-
Figure_9F_KCNQ2-Q3_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
30.37 KB
-
Figure_9G_KCNQ2-Q3_100_uM_Carnosic_acid_-_EM.csv.xlsx
9.22 KB
-
Figure_9I_KCNQ3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_Gmax.csv.xlsx
42.14 KB
-
Figure_9J_KCNQ3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_EM.csv.xlsx
9.31 KB
-
Figure_9L_KCNQ2-Q3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_Gmax.csv.xlsx
39.51 KB
-
Figure_9M_KCNQ2-Q3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_EM.csv.xlsx
9.33 KB
-
Figure_9N_Time_to_first_clonic_seizure.csv.xlsx
9.53 KB
-
Figure_9O_Time_to_first_tonic_seizure.csv.xlsx
9.54 KB
-
Figure_9P_Survival_Curves.csv.xlsx
10.26 KB
-
README.md
12.48 KB
Abstract
Isoform-selective opening of voltage-gated potassium (Kv) channels is desirable for its therapeutic potential yet mechanistically little understood. Rosemary leaf metabolite carnosic acid (CA) is a high-efficacy opener of the neuronal Kv7.3 channel but exerts minimal effects on Kv7.2 or Kv7.2/3 heteromers. Here, using alanine-scanning mutagenesis, electrophysiology, radioligand binding, and all-atom molecular dynamics simulations, we found that CA achieves high-efficacy activation of Kv7.3 by binding at the extracellular cap of the voltage-sensing domain (VSD), independent of the canonical retigabine pore binding site. Kv7.3 samples a binding-competent VSD conformation absent in Kv7.2, characterized by an expanded extracellular pocket and a favorable electrostatic environment. Central to this mechanism, Kv7.3-L226 functions as a hydrophobic latch that tunes the energetic landscape of the voltage sensor to control ligand efficacy. Unexpectedly, CA potentiates Kv7.2/3 activation by retigabine via ligand-initiated positive allosteric coupling between the VSD and pore, thus enhancing the anticonvulsant action of retigabine despite CA lacking standalone anticonvulsant activity. The findings establish a mechanistic framework in which isoform selectivity arises from VSD conformational microenvironments rather than canonical binding determinants and highlight the voltage sensor as a tunable target for developing selective Kv channel openers.
Authors: Rían W. Manville, Lorenzo Foglia, Ryan Yoshimura, Daniel E. Santos, Alvin Yu, and Geoffrey W. Abbott
Associated manuscript: PNAS
Data collection period: 2023 - 2026
Repository: Dryad Digital Repository
The dataset contains Excel files exported from the original analysis workbooks. All formulas were replaced by the resulting values during CSV export. These files were used to generate the corresponding panels for figures 1, 2, 3, 6, 7, and 9 in this manuscript. Each filename is structured to correspond to the figure in the manuscript:
Figure Number & panel > Channel Investigated > Condition > Parameter Measured
The repository contains data obtained from cellular electrophysiology recordings, radioligand-binding experiments, and mouse behavioral studies. We used two-electrode voltage clamp (TEVC) electrophysiology and the Xenopus laevis oocyte expression system to record the electrical activity of voltage-gated potassium (Kv) channels Kv7.2, Kv7.3, Kv7.3* (expression-enhancing Kv7.3-A315T construct), and Kv7.2/3 channels in response to carnosic acid. Additionally, we generated Kv7.3 and Kv7.2 mutations to ascertain the binding site and selectivity profile of carnosic acid. Xenopus laevis oocytes were injected with cRNA encoding for the following human potassium channels (genes encoding these channels denoted in brackets):
- Kv7.2/3 (KCNQ2/3)
- Kv7.2 (KCNQ2)
- Kv7.3* (KCNQ3)
All injected oocytes were incubated at 16°C for 24–96 h before TEVC recordings. The subsequent measurements were used to characterize the biophysical responses of these channels to carnosic acid.
The parameters measured as part of this study are as follows:
Gmax
These data were used to generate conductance-voltage curves (Gmax). Conductance-voltage curves were generated by normalizing the raw value of the tail current (recorded at -30 mV) to the peak tail-current amplitude. These conductance-voltage curves were then plotted as a function of the prepulse voltage and fitted with a single Boltzmann function:
g=A1+((A2-A1))/{1 + exp [(V(1/2)-V)/Vs]}
g: normalized tail-current amplitude, used as a measure of normalized conductance
(A1): lower asymptote
(A2): upper asymptote
(V): prepulse voltage
(V{1/2}): voltage of half-maximal activation
(Vs): slope factor
Defined column headings included for these CSV files
- Voltage (mV) - Prepulse voltage applied during the activation protocol
- Control - Normalized conductance from biological replicate/oocyte 1 under control conditions
- 10 or 100 uM Carnosic acid - Normalized conductance from the same oocyte after 10 or 100 uM carnosic acid
- Mean - Arithmetic mean across biological replicates
- SEM - Standard error of the mean
- n - Number of biologically independent oocytes
The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_2F_KCNQ3-S228A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_2H_KCNQ3-R242A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_2H_KCNQ3-R243A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_2J_KCNQ3-R236A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_2K_KCNQ3-L226A_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3B_KCNQ3-L226F_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3B_KCNQ3-L226V_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3B_KCNQ3-L226W_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3F_KCNQ3-L226Q_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3F_KCNQ3-L226S_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3H_KCNQ3-L226E_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_3H_KCNQ3-L226R_10_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_6E_KCNQ3L222F,-S225-A-L226_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_6E_KCNQ3-S225-A-L226_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_7D_KCNQ2-Q3_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_7F_KCNQ2-A196del_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_7F_KCNQ2-F192L__A196del_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_7F_KCNQ2-F192L_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_9C_KCNQ3_5_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_9F_KCNQ2-Q3_100_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_9I_KCNQ3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_Gmax.csv.xlsx
- Figure_9L_KCNQ2-Q3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_Gmax.csv.xlsx
Resting membrane potential
The resting membrane potential (EM) is the electrical potential difference across a cell's membrane at rest. The RMP is determined by the concentration of ions across the membrane and the membrane permeability to each type of ion. Here, we measured the RMP (EM) of unclamped Xenopus laevis oocytes expressing the above channels and reported the values in millivolts (mV).
Defined column headings included for these CSV files
- Voltage (mV) - Prepulse voltage applied during the activation protocol
- Control - Resting membrane potential from biological replicate/oocyte 1 under control conditions
- 10 or 100 uM Carnosic acid - Resting membrane potential from the same oocyte after 10 or 100 uM carnosic acid
- Mean - Arithmetic mean across biological replicates
- SEM - Standard error of the mean
- n - Number of biologically independent oocytes
The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_6F_KCNQ3-L222F__S225-A-L226_100_uM_Carnosic_acid_-_EM.csv.xlsx
- Figure_6F_KCNQ3-S225-A-L226_100_uM_Carnosic_acid_-_EM.csv.xlsx
- Figure_7H_KCNQ2_Mutants_100_uM_Carnosic_acid_-_Delta_EM_Shift.csv.xlsx
- Figure_9D_KCNQ3_5_uM_Carnosic_acid_-_EM.csv.xlsx
- Figure_9G_KCNQ2-Q3_100_uM_Carnosic_acid_-_EM.csv.xlsx
- Figure_9J_KCNQ3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_EM.csv.xlsx
- Figure_9M_KCNQ2-Q3_5_uM_Retigabine__5_uM_Retigabine___5_uM_Carnosic_acid_-_EM.csv.xlsx
Dose responses (ΔV0.5 shift) (mV)
These data were used to determine the potency and efficacy of carnosic acid at Kv7.3*, Kv7.3-L226A and Kv7.3-R236A channels. Carnosic acid was applied to Xenopus laevis oocytes expressing these channels at concentrations ranging from 0.01 - 100 uM. The tail current was then measured (as described above). All raw values are in millivolts (mV). The control V0.5 was subtracted from the V0.5 measured at each carnosic acid concentration. Negative delta V0.5 values represent hyperpolarizing shifts:
ΔV0.5 = V0.5,drug − V0.5, control
Defined column headings included for these CSV files
- Voltage (mV) - Prepulse voltage applied during the activation protocol
- Control - Normalized conductance from biological replicate/oocyte 1 under control conditions
- 0.01-100 uM Carnosic acid - Normalized conductance from the same oocyte after carnosic acid
- Mean - Arithmetic mean across biological replicates
- SEM - Standard error of the mean
- n - Number of biologically independent oocytes
The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_1E-G_KCNQ3_Carnosic_acid_Dose_Response_-_Gmax.csv.xlsx
- Figure_2M_KCNQ3-R236A_Carnosic_acid_Dose_Response_-_Gmax.csv.xlsx
- Figure_2N_KCNQ3-L226A_Carnosic_acid_Dose_Response_-_Gmax.csv.xlsx
Delta V0.5 shift: Mutants vs WT
These graphs were generated by taking the V0.5 shifts obtained from the Gmax of Kv7.3* alanine mutant channels. The mutant V0.5 values were then subtracted from the V0.5 value for WT Kv7.3* channels:
ΔV0.5 = V0.5,mutant − V0.5, wild type
These values were then displayed as a scatter graph. These data enable us to observe the effect Kv7.3* alanine mutations have on the voltage-dependence of activation compared to wild-type Kv7.3*. This informs us how these alanine mutations change the ability of the channel to open in response to changes in voltage across the cell membrane. All values are in millivolts (mV). The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_2A_KCNQ3_Alanine_Mutants_-_Delta_Voltage-dependence_Shift_vs_WT.csv.xlsx
- Figure_3C_Baseline_Voltage-dependence_Shift_vs_KCNQ3.csv.xlsx
- Figure_3I_Baseline_Voltage-dependence_Shift_vs_KCNQ3.csv.xlsx
Delta V0.5 shift: Control vs 10 uM Carnosic acid
These graphs were generated by taking the V0.5 shifts obtained from the Gmax of Kv7.3* alanine mutant channels in control solution and after application of 10 uM carnosic acid. These data were then displayed as a scatter plot. These data enable us to observe the effect of carnosic acid on the voltage-dependence of activation on the Kv7.3* alanine mutant channels. All values are in millivolts (mV). The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_2B_KCNQ3_Alanine_Mutants_-_10_uM_Carnosic_acid_Delta_Voltage-dependence_Shift.csv.xlsx
- Figure_3D_10_uM_Carnosic_acid_-_Delta_Voltage-dependence_Shift.csv.xlsx
- Figure_7G_KCNQ2_Mutants_100_uM_Carnosic_acid_-_Delta_Voltage-dependence_Shift.csv.xlsx
Tritiated GABA [3H GABA] Binding
These graphs were generated by assessing the radioactivity (Counts Per Minute; CPM) of cells injected with either water or Kv7.3* after incubation with tritiated GABA. Cells injected with Kv7.3* were either incubated in tritiated GABA alone or with 100 uM non-radioactive carnosic acid. These data help to inform whether GABA and carnosic acid are competing for the same binding site on the Kv7.3* channel. All values are in counts per minute (CPM).
Defined column headings included for these CSV files
- Water-injected - Radioactivity measured after 30 minutes incubation with [3H GABA]. Values are defined as counts per minute (CPM)
- Kv7.3* [3H GABA] - Radioactivity measured after 30 minutes incubation with [3H GABA]. Values are defined as counts per minute (CPM)
- Kv7.3* [3H GABA] + 100 uM Carnosic acid - Radioactivity measured after 30 minutes incubation with [3H GABA] + 100 uM carnosic acid. Values are defined as counts per minute (CPM)
The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_9A_Tritiated_GABA_vs_Carnosic_acid.csv.xlsx
Mouse Behavioral Studies
Chemoconvulsant seizure studies were conducted on mice using pentylenetetrazol (PTZ). Mice were injected with either vehicle (DMSO), carnosic acid, retigabine, or carnosic acid + retigabine 20 minutes prior to being injected with PTZ. Mice were then assessed for time to first clonic (seconds) or tonic seizure (seconds). Additionally, survival was monitored for 60 minutes after PTZ injection. Scores of 1 "survival" or 0 "deceased" were used. The data collected from these experiments help us assess whether carnosic acid and retigabine can synergize and protect against PTZ-induced seizures.
Defined column headings included for these CSV files
- Vehicle - Mice injected intraperitoneally with DMSO
- CA 1 mg/kg - Mice injected intraperitoneally with 1 mg/kg carnosic acid
- RET 10 mg/kg - Mice injected intraperitoneally with 10 mg/kg retigabine
- CA + RET - Mice injected intraperitoneally with a combination of 1 mg/kg carnosic acid and 10 mg/kg retigabine
The datasets pertaining to these measurements can be found in the following CSV files as part of this submission:
- Figure_9N_Time_to_first_clonic_seizure.csv.xlsx
- Figure_9O_Time_to_first_tonic_seizure.csv.xlsx
- Figure_9P_Survival_Curves.csv.xlsx
Statistics
Paired two-tailed Student’s t-tests were used for within-oocyte comparisons between control and drug conditions. One-way ANOVA followed by Dunnett’s multiple-comparisons test was used when multiple treatments or mutants were compared with a single control. Statistical results are reported in the associated manuscript; the deposited files contain the underlying observations only.
Additional Information
'n.a.' indicates that a measurement was not applicable and was therefore not collected.
Software required
The deposited files can be opened using any plain-text editor or spreadsheet/data-analysis software. GraphPad Prism was used for statistical analysis and graphing. Clampfit version 11.4 was used to analyze electrophysiological recordings. No proprietary software is required to access the deposited files.
cRNA preparation and Xenopus laevis oocyte injection
We generated cRNA transcripts encoding human Kv7.2 and Kv7.3 (wild-type and mutant) by in vitro transcription using the mMessage mMachine kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions, after vector linearization, from cDNA sub-cloned into expression vectors (pTLNx and pXOOM) incorporating Xenopus laevis β-globin 5’ and 3’ UTRs flanking the coding region to enhance translation and cRNA stability. Mutant Kv7 cDNAs were generated by Genscript (Piscataway, NJ, USA) and cRNAs made as above. We injected defolliculated stage V and VI Xenopus laevis oocytes (Xenoocyte, Dexter, MI, USA) with Kv7 cRNAs (2-10 ng) and incubated the oocytes at 16 oC in Barth’s solution oocyte storage solution containing penicillin and streptomycin, with daily washing, for 2-4 days prior to two-electrode voltage clamp (TEVC) recording.
Two-electrode voltage clamp (TEVC)
We performed TEVC at room temperature using an OC-725C amplifier (Warner Instruments, Hamden, CT, USA) and pClamp10 software (Molecular Devices, Sunnyvale, CA, USA) 2-4 days after cRNA injection. We placed oocytes in a small-volume oocyte bath (Warner) and viewed them with a dissection microscope for cellular electrophysiology. We sourced chemicals from Sigma-Aldrich (St. Louis, MO, USA) and Combi-Blocks (San Diego, CA, USA). We studied the effects of compounds solubilized directly in bath solution (in mM): 96 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES (pH 7.6). We introduced compounds into the oocyte recording bath by gravity perfusion at a constant flow of 1 ml per minute for 3 minutes prior to recording. Pipettes were of 1-2 MΩ resistance when filled with 3 M KCl. We recorded currents in response to voltage pulses between -150 mV, -120 mV or -80 mV and +40 mV at 10 mV intervals, followed by a tail pulse to -30 mV, from a holding potential of -80 mV, to yield current-voltage relationships. We analyzed data using Clampfit (Molecular Devices) and Graphpad Prism software (GraphPad, San Diego, CA, USA), stating values as mean ± SEM. We plotted raw or normalized tail currents versus prepulse voltage and fitted with a single Boltzmann function.
Pentylenetetrazol-induced seizure mouse model
Adult, male C57BL/6 mice (Charles River, Wilmington, MA) were group housed under a 12-hour light: dark cycle and given access to food and water ad libitum. The mice tested were between 7 and 13 weeks of age. This study was performed under an approved Institutional Animal Care and Use Committee protocol at the University of California, Irvine.
1 mg/mL of CA (Combi-Blocks, San Diego, CA), 10 mg/mL of free base retigabine dihydrochloride (Alomone Labs, Jerusalem, Israel), or a combination of the two were solubilized in DMSO. PTZ (Sigma-Aldrich, St. Louis, MO) was made up at 9 mg/mL in PBS.
Each animal initially received a 1 mL/kg intraperitoneal injection of vehicle, CA alone (1 mg/kg), retigabine alone (10 mg/kg), or CA and retigabine (1 mg/kg and 10 mg/kg, respectively). 30 minutes after the initial injection, each animal received a 10 mL/kg intraperitoneal injection of PTZ (90 mg/kg) and was placed in an empty home cage for observation for at least 60 minutes. The time and number of each occurrence of clonic and tonic seizures was recorded. The time of death was also recorded. Unless otherwise noted, all animals that survived for at least 60 minutes were also alive and appeared healthy at 24 hours.
